NDC properties for NDC 9 50090-6705
NDC item 50090670500
| NDC 9 | 50090-6705 |
|---|---|
| NDC 10 | 50090-6705-0 |
| NDC Item | 50090670500 |
| packaging | 1 SYRINGE in 1 CARTON (50090-6705-0) / .8 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 741662 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 78206018301
| NDC 9 | 78206-183 |
|---|---|
| NDC 10 | 78206-183-01 |
| NDC Item | 78206018301 |
| packaging | 2 CARTON in 1 CARTON (78206-183-01) / 1 SYRINGE in 1 CARTON (78206-183-99) / .8 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 78206018399
| NDC 9 | 78206-183 |
|---|---|
| NDC 10 | 78206-183-99 |
| NDC Item | 78206018399 |
| packaging | 0.8 mL in 1 SYRINGE |
| packaging | 1 in 1 CARTON |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |